Cargando…
The personalized antithrombotic management of atrial fibrillation with intermediate thromboembolic risk: a case report
BACKGROUND: So far there has been little evidence on the antithrombotic treatment of patients presenting with atrial fibrillation (AF) and a CHA(2)DS(2)-VASc score of 1 in men (2 in women). However, a recently published position paper suggests a personalized approach in weighing individual risk fact...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649479/ https://www.ncbi.nlm.nih.gov/pubmed/33204971 http://dx.doi.org/10.1093/ehjcr/ytaa176 |